Prescription attached:-

đŠē Prescription Analysis & Clinical Working Diagnosis
āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ āĻŦāĻŋāĻļā§āϞā§āώāĻŖ, āĻāώā§āϧā§āϰ āĻŦāĻŋāϏā§āϤāĻžāϰāĻŋāϤ āĻāĻŦāĻ āĻā§ā§āĻžāύā§āϤ āĻā§āϞāĻŋāύāĻŋāĻā§āϝāĻžāϞ āĻŽā§āϞā§āϝāĻžā§āύ
Author: Md. Rafiqul Islam Lipu
Date: Tuesday, 13 October 2026 (āĻŽāĻā§āĻāϞāĻŦāĻžāϰ, ā§§ā§Š āĻ āĻā§āĻā§āĻŦāϰ ⧍ā§Ļ⧍ā§Ŧ)
Time: 09:46 PM (Bangladesh Time)
Clinical References: Harrisonâs Principles of Internal Medicine, 22nd Edition; Davidsonâs Principles and Practice of Medicine, 25th Edition; Katzungâs Basic & Clinical Pharmacology, 16th Edition; NICE Guidelines; MedEx Bangladesh.
Prescription Review Note: āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύā§āϰ āĻšāĻžāϤā§āϰ āϞā§āĻāĻž āĻā§ā§āĻāĻāĻŋ āĻāĻžā§āĻāĻžā§ āĻ āϏā§āĻĒāώā§āĻāĨ¤ āϝā§āĻā§āϞ⧠āύāĻŋāϰā§āĻāϰāϝā§āĻā§āϝāĻāĻžāĻŦā§ āĻĒā§āĻž āϝāĻžāĻā§āĻā§, āϏā§āĻā§āϞ⧠āύāĻŋāĻļā§āĻāĻŋāϤāĻāĻžāĻŦā§ āĻāϞā§āϞā§āĻ āĻāϰā§āĻāĻŋāĨ¤ āĻ āϏā§āĻĒāώā§āĻ āĻ āĻāĻļā§ āϏāĻŽā§āĻāĻžāĻŦā§āϝ āĻĒāĻžāĻ āĻĻāĻŋā§ā§āĻāĻŋ, āĻāĻŋāύā§āϤ⧠āϏā§āĻā§āϞā§āĻā§ āύāĻŋāĻļā§āĻāĻŋāϤ āϤāĻĨā§āϝ āĻšāĻŋāϏā§āĻŦā§ āĻāĻĒāϏā§āĻĨāĻžāĻĒāύ āĻāϰāĻŋāύāĻŋāĨ¤ āĻļā§āϧ⧠āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ āĻĻā§āĻā§ āϰā§āĻā§āϰ āĻāĻžāϰāĻŖ āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāĻž āϏāĻŽā§āĻāĻŦ āύā§āĨ¤
1. Patient Information â āϰā§āĻā§āϰ āϤāĻĨā§āϝ
| āĻŦāĻŋāώ⧠| āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύā§āϰ āϤāĻĨā§āϝ |
|---|---|
| Hospital | āĻāĻĒāĻā§āϞāĻž āϏā§āĻŦāĻžāϏā§āĻĨā§āϝ āĻāĻŽāĻĒā§āϞā§āĻā§āϏ, āĻŽāĻĻāύ, āύā§āϤā§āϰāĻā§āĻŖāĻž |
| Department | Outpatient Department (āĻŦāĻšāĻŋāϰā§āĻŦāĻŋāĻāĻžāĻ) |
| Age (āĻŦā§āϏ) | āĻāύā§āĻŽāĻžāύāĻŋāĻ ā§Ģā§Ļ āĻŦāĻāϰ |
| Sex (āϞāĻŋāĻā§āĻ) | āϏā§āĻĒāώā§āĻāĻāĻžāĻŦā§ āĻāϞā§āϞā§āĻ āύā§āĻ |
| Patient Name | āĻšāĻžāϤā§āϰ āϞā§āĻāĻž āĻ āϏā§āĻĒāώā§āĻ |
| Prescribing Physician | āϏāĻŋāϞ āĻ āύā§āϝāĻžā§ā§ Dr. Nurul Huda |
| Prescription Date | āϏā§āĻĒāώā§āĻ āύ⧠|
2. C/C â Chief Complaints (āĻĒā§āϰāϧāĻžāύ āĻ āĻāĻŋāϝā§āĻ)
āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύā§āϰ āĻŦāĻžāĻŽ āĻĒāĻžāĻļā§ āϰā§āĻā§āϰ āĻŦāĻŋāĻŦāϰāĻŖ āĻ āĻāĻļā§ āϤāĻŋāύāĻāĻŋ āĻŦāĻŋāώ⧠āĻĒāĻžāĻā§āĻž āϝāĻžāĻā§āĻā§āĨ¤
| C/C | English | āĻŦāĻžāĻāϞāĻž āĻ āϰā§āĻĨ | Confidence |
|---|---|---|---|
| 1 | Vertigo | āĻŽāĻžāĻĨāĻž āĻā§āϰāĻž āĻŦāĻž āĻāĻžāϰāĻĒāĻžāĻļ āĻā§āϰāĻā§ āĻŦāϞ⧠āĻ āύā§āĻā§āϤ āĻšāĻā§āĻž | 98% |
| 2 | Decreased Sleep | āĻā§āĻŽ āĻāĻŽ āĻšāĻā§āĻž āĻŦāĻž āĻā§āĻŽā§āϰ āϏāĻŽāϏā§āϝāĻž | 98% |
| 3 | DM (â) | āϏāĻŽā§āĻāĻŦāϤ āĻĄāĻžā§āĻžāĻŦā§āĻāĻŋāϏā§āϰ āĻāϤāĻŋāĻšāĻžāϏ āύā§āĻ | 80% |
Clinical Interpretation â āĻā§āϞāĻŋāύāĻŋāĻā§āϝāĻžāϞ āĻŦā§āϝāĻžāĻā§āϝāĻž
1. Vertigo â āĻŽāĻžāĻĨāĻž āĻā§āϰāĻž
Vertigo āĻŦāϞāϤ⧠āϰā§āĻā§āϰ āύāĻŋāĻā§āϰ āĻļāϰā§āϰ āĻ āĻĨāĻŦāĻž āĻāĻžāϰāĻĒāĻžāĻļ āĻā§āϰāĻā§ āĻŦāϞ⧠āĻ āύā§āĻā§āϤ āĻšāĻā§āĻžāĻā§ āĻŦā§āĻāĻžā§āĨ¤
āϏāĻŽā§āĻāĻžāĻŦā§āϝ āĻāĻžāϰāĻŖā§āϰ āĻŽāϧā§āϝ⧠āϰā§ā§āĻā§:
- Benign Paroxysmal Positional Vertigo (BPPV)
- Vestibular neuritis
- MÊnièreâs disease
- Vestibular migraine
- Central vestibular disorders
āĻ āĻāĻžā§āĻž āϰā§āĻā§ āϝāĻĻāĻŋ āĻĒā§āϰāĻā§āϤ āĻā§āϰā§āĻŖāύā§āϰ āĻĒāϰāĻŋāĻŦāϰā§āϤ⧠āĻŽāĻžāĻĨāĻž āĻšāĻžāϞāĻāĻž āϞāĻžāĻāĻž āĻŦā§āĻāĻžāύ, āϤāĻžāĻšāϞ⧠Orthostatic hypotension, cardiac arrhythmia āĻ āĻĨāĻŦāĻž āĻ āύā§āϝāĻžāύā§āϝ āĻāĻžāϰāĻŖ āĻŦāĻŋāĻŦā§āĻāύāĻž āĻāϰāϤ⧠āĻšāĻŦā§āĨ¤
2. Decreased Sleep â āĻā§āĻŽ āĻāĻŽ āĻšāĻā§āĻž
āĻāĻāĻŋ Insomnia-āĻāϰ āĻāĻāĻāĻŋ āĻāĻĒāϏāϰā§āĻ āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤
āϤāĻŦā§ āĻāϤāĻĻāĻŋāύ āϧāϰ⧠āĻā§āĻŽ āĻāĻŽ āĻšāĻā§āĻā§ āĻāĻŦāĻ āĻĻā§āύāύā§āĻĻāĻŋāύ āĻāĻžāĻā§ āĻĒā§āϰāĻāĻžāĻŦ āĻĒā§āĻā§ āĻāĻŋ āύāĻž, āϤāĻž āύāĻž āĻā§āύ⧠Chronic Insomnia Disorder āĻŦāϞāĻž āϝāĻžāĻŦā§ āύāĻžāĨ¤
3. DM (â) â Diabetes Mellitus Negative
āĻāĻŋāĻāĻŋā§āϏāĻ āϏāĻŽā§āĻāĻŦāϤ āϰā§āĻā§āϰ āĻĒā§āϰā§āĻŦā§ āĻĄāĻžā§āĻžāĻŦā§āĻāĻŋāϏ āύāĻž āĻĨāĻžāĻāĻžāϰ āĻāϤāĻŋāĻšāĻžāϏ āϞāĻŋāĻā§āĻā§āύāĨ¤
āĻāĻāĻŋ āĻĒāϰā§āĻā§āώāĻžāϰ āĻŽāĻžāϧā§āϝāĻŽā§ āĻĄāĻžā§āĻžāĻŦā§āĻāĻŋāϏ āύā§āĻâāĻāĻŽāύ āĻĒā§āϰāĻŽāĻžāĻŖ āύā§āĨ¤
Textbook Reference: Harrisonâs Principles of Internal Medicine, 22nd Edition, Chapter 24: Dizziness and Vertigo.
3. O/E â On Examination (āĻļāĻžāϰā§āϰāĻŋāĻ āĻĒāϰā§āĻā§āώāĻžā§ āĻĒā§āϰāĻžāĻĒā§āϤ āϤāĻĨā§āϝ)
āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύā§āϰ āύāĻŋāĻā§āϰ āĻ āĻāĻļā§ āĻĻā§āĻāĻŋ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ Vital Sign āϞā§āĻāĻž āĻāĻā§āĨ¤
| Parameter | Recorded Finding | Clinical Interpretation |
|---|---|---|
| Blood Pressure | 144/99 mmHg | Elevated blood pressure â āĻāĻā§āĻ āϰāĻā§āϤāĻāĻžāĻĒā§āϰ āϰāĻŋāĻĄāĻŋāĻ |
| Pulse Rate | 103/min | Tachycardia â āϏā§āĻŦāĻžāĻāĻžāĻŦāĻŋāĻā§āϰ āϤā§āϞāύāĻžā§ āĻĻā§āϰā§āϤ āĻĒāĻžāϞāϏ |
A. Blood Pressure: 144/99 mmHg
Clinical Assessment: Elevated Blood Pressure
NICE NG136 āĻ āύā§āϝāĻžā§ā§ āĻā§āϞāĻŋāύāĻŋāĻā§ BP âĨ140/90 mmHg āĻšāϞ⧠āĻĒā§āύāϰāĻžā§ āĻŽāĻžāĻĒāϤ⧠āĻšāĻŦā§ āĻāĻŦāĻ āĻĒā§āϰā§ā§āĻāύ āĻ āύā§āϝāĻžā§ā§ ABPM/HBPM āĻĻāĻŋā§ā§ Hypertension āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāϤ⧠āĻšāĻŦā§āĨ¤
āϏā§āϤāϰāĻžāĻ āĻāĻāĻžāύā§:
- āϰāĻā§āϤāĻāĻžāĻĒ āϏā§āĻŦāĻžāĻāĻžāĻŦāĻŋāĻā§āϰ āĻā§ā§ā§ āĻŦā§āĻļāĻŋāĨ¤
- āĻāĻāĻāĻŋ āϰāĻŋāĻĄāĻŋāĻ āĻĻāĻŋā§ā§ āϏā§āĻĨāĻžā§ā§ Hypertension āύāĻŋāĻļā§āĻāĻŋāϤ āύā§āĨ¤
- āĻāĻā§ āĻĨā§āĻā§ āĻāĻā§āĻ āϰāĻā§āϤāĻāĻžāĻĒ āĻāĻā§ āĻāĻŋ āύāĻž āĻāĻžāύāĻž āĻĒā§āϰā§ā§āĻāύāĨ¤
- āϰā§āĻā§āϰ āĻŽāĻžāĻĨāĻž āĻā§āϰāĻžāϰ āĻāĻžāϰāĻŖ āĻļā§āϧ⧠BP āϧāϰ⧠āύā§āĻā§āĻž āϝāĻžāĻŦā§ āύāĻžāĨ¤
Confidence: 98% â āϝāĻĻāĻŋ āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύā§āϰ āϰāĻŋāĻĄāĻŋāĻ 144/99 āϏāĻ āĻŋāĻāĻāĻžāĻŦā§ āĻĒā§āĻž āĻšā§ā§ āĻĨāĻžāĻā§āĨ¤
B. Pulse Rate: 103/min
Clinical Assessment: Tachycardia
āĻĒā§āϰāĻžāĻĒā§āϤāĻŦā§āϏā§āĻ āĻŦā§āϝāĻā§āϤāĻŋāϰ āĻŦāĻŋāĻļā§āϰāĻžāĻŽāĻāĻžāϞā§āύ āĻĒāĻžāϞāϏ āϏāĻžāϧāĻžāϰāĻŖāϤ 60â100/mināĨ¤
āĻāĻāĻžāύ⧠103/min āĻšāĻā§āĻžā§ āĻĒāĻžāϞāϏ āϏāĻžāĻŽāĻžāύā§āϝ āĻŦā§āĻļāĻŋāĨ¤
āϏāĻŽā§āĻāĻžāĻŦā§āϝ āĻāĻžāϰāĻŖ:
- Anxiety â āĻāĻĻā§āĻŦā§āĻ
- Dehydration â āĻĒāĻžāύāĻŋāĻļā§āύā§āϝāϤāĻž
- Pain or physiological stress â āĻŦā§āϝāĻĨāĻž āĻŦāĻž āĻļāĻžāϰā§āϰāĻŋāĻ āĻāĻžāĻĒ
- Anemia â āϰāĻā§āϤāϏā§āĻŦāϞā§āĻĒāϤāĻž
- Hyperthyroidism â āĻĨāĻžāĻāϰā§ā§āĻĄ āĻšāϰāĻŽā§āύ āĻŦā§ā§ā§ āϝāĻžāĻā§āĻž
- Cardiac arrhythmia â āĻšā§āĻĻā§âāϏā§āĻĒāύā§āĻĻāύā§āϰ āĻāύā§āĻĻā§āϰ āϏāĻŽāϏā§āϝāĻž
āĻŦāĻŋāĻļā§āώ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ: Pulse 103/min āĻĒāĻžāĻā§āĻž āĻā§āϞā§āĻ ECG āύāĻž āĻĻā§āĻā§ Sinus Tachycardia āύāĻŋāĻļā§āĻāĻŋāϤ āĻŦāϞāĻž āϝāĻžā§ āύāĻžāĨ¤
4. Patient History â āĻāĻŋāĻāĻŋā§āϏāĻ āĻā§ āĻā§ āĻāϤāĻŋāĻšāĻžāϏ āĻāϞā§āϞā§āĻ āĻāϰā§āĻā§āύ?
āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠āĻĒāĻžāĻā§āĻž āϤāĻĨā§āϝāĻā§āϞā§:
| History | Documentation |
|---|---|
| Vertigo | â Mentioned |
| Sleep disturbance | â Mentioned |
| Diabetes mellitus | āϏāĻŽā§āĻāĻŦāϤ Negative |
| Hypertension history | Not mentioned |
| Previous stroke/TIA | Not mentioned |
| Hearing loss | Not mentioned |
| Tinnitus | Not mentioned |
| Nausea/Vomiting | Not mentioned |
| Headache/Migraine | Not mentioned |
| Drug history | Not mentioned |
| Allergy history | Not mentioned |
| Duration of symptoms | Not clearly mentioned |
āĻāĻāĻžāύ⧠Not mentioned āĻ āϰā§āĻĨ āϰā§āĻā§āϰ āϏāĻŽāϏā§āϝāĻž āύā§āĻ āύā§; āĻŦāϰāĻ āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠āϤāĻĨā§āϝāĻāĻŋ āĻĒāĻžāĻā§āĻž āϝāĻžā§āύāĻŋāĨ¤
Clinical Concern
Vertigo āϰā§āĻā§āϰ āĻā§āώā§āϤā§āϰ⧠āϏāĻŦāĻā§ā§ā§ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ āĻāϤāĻŋāĻšāĻžāϏāĻā§āϞā§āϰ āĻāĻāĻāĻŋ āĻšāϞā§:
āĻŽāĻžāĻĨāĻž āĻā§āϰāĻžāĻāĻž āĻāĻŋ āĻŦāĻŋāĻāĻžāύāĻžā§ āĻĒāĻžāĻļ āĻĢāĻŋāϰāϞ⧠āĻŦāĻž āĻŽāĻžāĻĨāĻžāϰ āĻ āĻŦāϏā§āĻĨāĻžāύ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ āĻāϰāϞ⧠āĻļā§āϰ⧠āĻšā§, āύāĻžāĻāĻŋ āĻāĻāĻāĻžāύāĻž āĻĨāĻžāĻā§?
āĻāĻ āϤāĻĨā§āϝ āĻāĻžā§āĻž BPPV, vestibular neuritis āĻāĻŦāĻ central vertigo-āĻāϰ āĻŽāϧā§āϝ⧠āύāĻŋāϰā§āĻāϰāϝā§āĻā§āϝ āĻĒāĻžāϰā§āĻĨāĻā§āϝ āĻāϰāĻž āϝāĻžā§ āύāĻžāĨ¤
5. Investigation Analysis â āĻĒāϰā§āĻā§āώāĻž-āύāĻŋāϰā§āĻā§āώāĻžāϰ āĻŦāĻŋāĻļā§āϞā§āώāĻŖ
āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύā§āϰ Adv. āĻ āĻāĻļā§ āĻā§ā§āĻāĻāĻŋ āĻĒāϰā§āĻā§āώāĻžāϰ āύāĻžāĻŽ āĻ āϏāĻŽā§āĻāĻžāĻŦā§āϝ āĻĢāϞ āϞā§āĻāĻž āϰā§ā§āĻā§āĨ¤
āĻšāĻžāϤā§āϰ āϞā§āĻāĻž āĻ āύā§āϝāĻžā§ā§:
| Investigation | āϏāĻŽā§āĻāĻžāĻŦā§āϝ Recorded Finding | Clinical Interpretation |
|---|---|---|
| Serum Creatinine / āĻ āύā§āϝ Serum Test | 0.6 āĻŦāĻž 10.6-āĻāϰ āĻŽāϤā§; āĻ āϏā§āĻĒāώā§āĻ | āĻĒāϰā§āĻā§āώāĻžāϰ āύāĻžāĻŽ āĻ āĻŽāĻžāύ āύāĻŋāĻļā§āĻāĻŋāϤ āύ⧠|
| ECG | N (Normal) | āϏāĻŽā§āĻāĻŦāϤ āϏā§āĻŦāĻžāĻāĻžāĻŦāĻŋāĻ ECG |
| CBC | 12.4 āĻāĻŦāĻ 20 | āĻā§āύ āĻŽāĻžāύ āĻā§āύ āĻĒā§āϝāĻžāϰāĻžāĻŽāĻŋāĻāĻžāϰā§āϰ, āύāĻŋāĻļā§āĻāĻŋāϤ āύ⧠|
| RBS | 6.8 | Random Blood Sugar āĻšāϤ⧠āĻĒāĻžāϰā§; āĻāĻāĻ āϞā§āĻāĻž āύā§āĻ |
1. ECG â Electrocardiogram
āĻŦāĻžāĻāϞāĻž: āĻšā§āĻĻā§âāϝāύā§āϤā§āϰā§āϰ āĻŦā§āĻĻā§āϝā§āϤāĻŋāĻ āĻāĻžāϰā§āϝāĻā§āϰāĻŽ āĻĒāϰā§āĻā§āώāĻžāĨ¤
āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠ECG-āĻāϰ āĻĒāĻžāĻļā§ āĻāĻāĻāĻŋ āĻŦā§āϤā§āϤā§āϰ āĻŽāϧā§āϝ⧠N āĻĻā§āĻāĻž āϝāĻžāĻā§āĻā§āĨ¤
āϏāĻŽā§āĻāĻŦāϤ āĻāĻŋāĻāĻŋā§āϏāĻ ECG Normal āϞāĻŋāĻā§āĻā§āύāĨ¤
āϤāĻŦā§ āϏā§āĻŦāĻžāĻāĻžāĻŦāĻŋāĻ ECG āĻĨāĻžāĻāϞā§āĻ āĻŽāĻžāĻā§āĻŽāϧā§āϝ⧠āĻšāĻā§āĻž Arrhythmia āϏāĻŽā§āĻĒā§āϰā§āĻŖ āĻŦāĻžāĻĻ āĻĻā§āĻā§āĻž āϝāĻžā§ āύāĻžāĨ¤
2. CBC â Complete Blood Count
āĻŦāĻžāĻāϞāĻž: āĻĒā§āϰā§āĻŖāĻžāĻā§āĻ āϰāĻā§āϤ āĻĒāϰā§āĻā§āώāĻžāĨ¤
āϏāĻŽā§āĻāĻŦāϤ CBC-āĻāϰ āĻĒāĻžāĻļā§ 12.4 āĻāĻŦāĻ 20 āϞā§āĻāĻž āĻāĻā§āĨ¤
12.4 āϝāĻĻāĻŋ Hemoglobin (Hb) āĻšā§, āϤāĻžāĻšāϞ⧠āϰā§āĻā§āϰ āϞāĻŋāĻā§āĻ āĻ āϞā§āϝāĻžāĻŦā§āϰ Reference Range āĻ āύā§āϝāĻžā§ā§ āĻŽā§āϞā§āϝāĻžā§āύ āĻāϰāϤ⧠āĻšāĻŦā§āĨ¤
20 āϏāĻāĻā§āϝāĻžāĻāĻŋ ESR āĻāĻŋ āύāĻž, āύāĻŋāĻļā§āĻāĻŋāϤ āĻšāĻā§āĻž āϝāĻžāĻā§āĻā§ āύāĻžāĨ¤
3. RBS â Random Blood Sugar
āĻŦāĻžāĻāϞāĻž: āϝā§āĻā§āύ⧠āϏāĻŽā§ā§ āϰāĻā§āϤ⧠āĻā§āϞā§āĻā§āĻā§āϰ āĻŽāĻžāϤā§āϰāĻžāĨ¤
āϏāĻŽā§āĻāĻžāĻŦā§āϝ āĻŽāĻžāύ: 6.8āĨ¤
āϝāĻĻāĻŋ āĻāĻāĻ mmol/L āĻšā§, āϤāĻžāĻšāϞ⧠āĻāĻāĻŋ āĻāĻāĻž āĻĄāĻžā§āĻžāĻŦā§āĻāĻŋāϏ āύāĻŋāϰā§āĻŖā§ā§āϰ āĻāύā§āϝ āϝāĻĨā§āώā§āĻ āύā§āĨ¤ āĻāĻāĻ āύāĻŋāĻļā§āĻāĻŋāϤ āύāĻž āĻšāϞ⧠āĻĢāϞāĻāĻŋāϰ āĻā§ā§āĻžāύā§āϤ āĻŦā§āϝāĻžāĻā§āϝāĻž āĻāϰāĻž āϝāĻžāĻŦā§ āύāĻžāĨ¤
4. Serum Test
āĻĒā§āϰāĻĨāĻŽ āϞāĻžāĻāύā§āϰ āĻĒāϰā§āĻā§āώāĻžāϰ āύāĻžāĻŽ āĻāĻŦāĻ āĻĢāϞ āϏā§āĻĒāώā§āĻāĻāĻžāĻŦā§ āĻĒā§āĻž āϝāĻžāĻā§āĻā§ āύāĻžāĨ¤
āĻāĻāĻŋ Serum Creatinine āĻŦāĻž āĻ āύā§āϝ āĻā§āύ⧠Serum Investigation āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤
Clinical Decision: āĻŽā§āϞ āϞā§āϝāĻžāĻŦāϰā§āĻāϰāĻŋ āϰāĻŋāĻĒā§āϰā§āĻ āĻāĻžā§āĻž āĻāĻŋāĻĄāύāĻŋ, āĻā§āϝāĻžāϞāϏāĻŋā§āĻžāĻŽ āĻŦāĻž āĻ āύā§āϝ āĻā§āύ⧠āĻŦāĻžā§ā§āĻā§āĻŽāĻŋāĻā§āϝāĻžāϞ āĻ āϏā§āĻŦāĻžāĻāĻžāĻŦāĻŋāĻāϤāĻž āύāĻŋāϰā§āĻŖā§ āĻāϰāĻž āĻāĻāĻŋāϤ āύā§āĨ¤
Investigation Status
Adv. āĻ āĻāĻļā§ āĻĢāϞā§āϰ āĻŽāϤ⧠āϏāĻāĻā§āϝāĻž āϞā§āĻāĻž āĻĨāĻžāĻāĻžā§ āĻāĻā§āϞ⧠āĻāĻā§ āĻāϰāĻž āĻĒāϰā§āĻā§āώāĻžāϰ āĻĢāϞāĻ āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤ āϏāĻŦāĻā§āϞā§āĻā§ āύāϤā§āύ āĻāϰ⧠āĻĻā§āĻā§āĻž Investigation Order āĻŦāϞāĻž āϝāĻžāĻā§āĻā§ āύāĻžāĨ¤
Confidence: ECG āĻ RBS āĻļāύāĻžāĻā§āϤāĻāϰāĻŖā§ āĻŽāĻžāĻāĻžāϰāĻŋ āĻĨā§āĻā§ āĻāĻā§āĻ; āĻ āύā§āϝāĻžāύā§āϝ āĻĢāϞā§āϰ āĻŦā§āϝāĻžāĻā§āϝāĻžā§ āĻāĻŽāĨ¤
đĸ 7. Prescribed Drug Analysis â MedEx āĻ āύā§āϝāĻžā§ā§
āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠āĻŽā§āĻ ā§ĒāĻāĻŋ āĻāώā§āϧ āϞā§āĻāĻž āĻāĻā§ āĻŦāϞ⧠āĻŽāύ⧠āĻšāĻā§āĻā§āĨ¤
| SL | Brand Name | Generic Name | Strength |
|---|---|---|---|
| 1 | Vertina-D | Pyridoxine + Doxylamine | 10 mg + 10 mg |
| 2 | Filfresh | Melatonin | 3 mg |
| 3 | Astagen | Astaxanthin | 2 mg |
| 4 | Bicozin-I Syrup | Iron Polymaltose + Vitamin B Complex + Zinc | Combination Syrup |
āĻāώā§āϧāĻā§āϞā§āϰ āύāĻžāĻŽ MedEx-āĻāϰ āϏāĻā§āĻā§ āĻŽāĻŋāϞāĻŋā§ā§ āϝāĻžāĻāĻžāĻ āĻāϰāĻž āĻšā§ā§āĻā§āĨ¤ āϤā§āϤā§ā§ āĻ āĻāϤā§āϰā§āĻĨ āύāĻžāĻŽā§āϰ āĻĒāĻžāĻ āϏāĻŽā§āĻāĻžāĻŦā§āϝ āĻšāϞā§āĻ āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāϤ⧠āĻŽā§āϞ āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ āĻŦāĻž āĻāώā§āϧā§āϰ āĻĒā§āϝāĻžāĻā§āĻ āĻĻā§āĻāĻž āĻāĻāĻŋāϤāĨ¤
đ 1. Vertina-D Tablet
Brand Information
| Information | Details |
|---|---|
| BD Brand Name | Vertina-D |
| Generic Name | Pyridoxine Hydrochloride + Doxylamine Succinate |
| Strength | 10 mg + 10 mg |
| Manufacturer | Square Pharmaceuticals PLC |
| MedEx Therapeutic Class | Anti-emetic drugs |
| Pharmacological Class | H1 Antihistamine + Vitamin B6 |
| Unit Price | ā§ŗ5.00 |
| Strip Price | ā§ŗ50.00 (10 tablets) |
| Other Strength | Vertina-DX 20 mg + 20 mg |
MedEx Link: Vertina-D 10 mg + 10 mg
āϤāĻĨā§āϝ āĻ āĻŽā§āϞā§āϝ MedEx āĻ āύā§āϝāĻžā§ā§āĨ¤
Use of Purpose â āĻā§ āĻāĻžāĻā§ āĻŦā§āϝāĻŦāĻšā§āϤ āĻšā§?
Vertina-D āĻŽā§āϞāϤ āĻāϰā§āĻāĻžāĻŦāϏā§āĻĨāĻžāϰ āĻŦāĻŽāĻŋ āĻŦāĻŽāĻŋ āĻāĻžāĻŦ āĻ āĻŦāĻŽāĻŋāϰ āĻāĻŋāĻāĻŋā§āϏāĻžā§ āĻŦā§āϝāĻŦāĻšā§āϤ āĻšā§āĨ¤
āĻāϰ āĻĻā§āĻāĻŋ āĻāĻĒāĻžāĻĻāĻžāύ:
Doxylamine: First-generation H1 antihistamineāĨ¤ āĻāĻāĻŋ āĻŦāĻŽāĻŋ āĻŦāĻŽāĻŋ āĻāĻžāĻŦ āĻāĻŽāĻžāϤ⧠āϏāĻžāĻšāĻžāϝā§āϝ āĻāϰ⧠āĻāĻŦāĻ āĻā§āĻŽ āĻā§āĻŽ āĻāĻžāĻŦ āϏā§āώā§āĻāĻŋ āĻāϰāϤ⧠āĻĒāĻžāϰā§āĨ¤
Pyridoxine: Vitamin B6āĨ¤ āĻŦāĻŽāĻŋ āĻŦāĻŽāĻŋ āĻāĻžāĻŦā§āϰ āĻāĻŋāĻāĻŋā§āϏāĻžā§ āĻŦā§āϝāĻŦāĻšā§āϤ āĻšā§āĨ¤
Why Doctor Prescribed It in This Patient?
āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠Vertigo āĻāϞā§āϞā§āĻ āĻĨāĻžāĻāĻžā§ āĻāĻŋāĻāĻŋā§āϏāĻ āĻšā§āϤ⧠āĻŽāĻžāĻĨāĻž āĻā§āϰāĻžāϰ āϏāĻā§āĻā§ āĻĨāĻžāĻāĻž āĻ āϏā§āĻŦāϏā§āϤāĻŋ āĻŦāĻž āĻŦāĻŽāĻŋ āĻŦāĻŽāĻŋ āĻāĻžāĻŦ āĻāĻŽāĻžāύā§āϰ āĻāĻĻā§āĻĻā§āĻļā§āϝ⧠āĻāώā§āϧāĻāĻŋ āĻĻāĻŋā§ā§āĻā§āύāĨ¤
āϤāĻŦā§ āĻāĻāĻāĻŋ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ āĻŦāĻŋāώā§:
Vertina-D āĻšāϞ⧠āĻŽā§āϞāϤ Nausea and Vomiting of Pregnancy-āĻāϰ āĻāώā§āϧāĨ¤ āĻāĻāĻŋ āϏāĻžāϧāĻžāϰāĻŖ Vertigo āĻŦāĻž BPPV-āĻāϰ āĻĒā§āϰāϤāĻŋāώā§āĻ āĻŋāϤ āĻĒā§āϰāĻĨāĻŽ āϏāĻžāϰāĻŋāϰ āĻāĻŋāĻāĻŋā§āϏāĻž āύā§āĨ¤
āĻ āϰā§āĻā§āϰ āĻā§āώā§āϤā§āϰ⧠āĻāĻāĻŋ āĻĻā§āĻā§āĻžāϰ āϏā§āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ āĻāĻžāϰāĻŖ āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ āĻĨā§āĻā§ āύāĻŋāĻļā§āĻāĻŋāϤ āĻšāĻā§āĻž āϝāĻžāĻā§āĻā§ āύāĻžāĨ¤
Dose in Prescription
āϞā§āĻāĻž āĻ āύā§āϝāĻžā§ā§ āϏāĻŽā§āĻāĻŦāϤ ā§§+ā§Ļ+ā§§ āϰā§ā§āĻā§āĨ¤ āĻāĻŋāĻāĻŋā§āϏāĻžāϰ āϏāĻŽā§āĻāĻžāϞ āϏā§āĻĒāώā§āĻ āύā§āĨ¤
āĻāĻ āĻāώā§āϧā§āϰ Delayed Release Formulation-āĻāϰ āĻā§āώā§āϤā§āϰ⧠MedEx-āĻāϰ āύāĻŋā§āĻŽāĻŋāϤ āĻĄā§āĻ āύāĻŋāϰā§āĻĻā§āĻļāύāĻž āĻāϰ āĻĨā§āĻā§ āĻāĻŋāύā§āύ āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤ āϤāĻžāĻ āĻšāĻžāϤ⧠āϞā§āĻāĻž āĻĄā§āĻāĻāĻŋ āĻāĻŋāĻāĻŋā§āϏāĻā§āϰ āϏāĻā§āĻā§ āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāĻž āĻāϰā§āϰāĻŋāĨ¤
Important Side Effects
- Drowsiness â āĻā§āĻŽ āĻā§āĻŽ āĻāĻžāĻŦ
- Dry mouth â āĻŽā§āĻ āĻļā§āĻāĻžāύā§
- Dizziness â āĻŽāĻžāĻĨāĻž āĻā§āϰāĻž āĻŦā§ā§ā§ āϝā§āϤ⧠āĻĒāĻžāϰā§
- Impaired alertness â āĻŽāύā§āϝā§āĻ āĻ āϏāϤāϰā§āĻāϤāĻž āĻāĻŽā§ āϝāĻžāĻā§āĻž
āϰā§āĻā§āϰ āĻāĻā§ āĻĨā§āĻā§āĻ Vertigo āĻĨāĻžāĻāĻžā§ āĻ āϤāĻŋāϰāĻŋāĻā§āϤ āĻāĻŋāĻŽā§āύāĻŋ āĻĒā§ā§ āϝāĻžāĻā§āĻžāϰ āĻā§āĻāĻāĻŋ āĻŦāĻžā§āĻžāϤ⧠āĻĒāĻžāϰā§āĨ¤
Alternative Bangladesh Brands
āĻāĻāĻ Generic Combination-āĻāϰ āĻā§ā§āĻāĻāĻŋ āĻŦā§āϰā§āϝāĻžāύā§āĻĄ:
- Vomix DR â Beximco
- Pregmos â Renata
- Novea â Healthcare
- Dicliz Plus â Aristopharma
- Inmit â Radiant
āĻāϏāĻŦ āĻāĻāĻ āϧāϰāύā§āϰ Generic-āĻāϰ āĻŦāĻŋāĻāϞā§āĻĒ; āĻāĻŋāĻāĻŋā§āϏāĻā§āϰ āĻĒāϰāĻžāĻŽāϰā§āĻļ āĻāĻžā§āĻž āĻāĻāĻāĻŋāϰ āĻĒāϰāĻŋāĻŦāϰā§āϤ⧠āĻāϰā§āĻāĻāĻŋ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻāϰāĻž āĻāĻāĻŋāϤ āύā§āĨ¤
đ 2. Filfresh 3 mg Tablet
Brand Information
| Information | Details |
|---|---|
| BD Brand Name | Filfresh |
| Generic Name | Melatonin |
| Strength | 3 mg |
| Manufacturer | Square Pharmaceuticals PLC |
| MedEx Therapeutic Class | Hormone preparations for other uses, Oral nutritional preparations |
| Pharmacological Class | Melatonin receptor agonist / Endogenous pineal hormone |
| Unit Price | ā§ŗ3.01 |
| Strip Price | ā§ŗ30.10 (10 tablets) |
| Available Strength of Filfresh | 3 mg |
MedEx Link: Filfresh 3 mg Tablet
Use of Purpose â āĻā§āύ āϰā§āĻā§ āĻŦā§āϝāĻŦāĻšā§āϤ āĻšā§?
Melatonin āĻĒā§āϰāϧāĻžāύāϤ SleepâWake Cycle āύāĻŋā§āύā§āϤā§āϰāĻŖā§ āĻā§āĻŽāĻŋāĻāĻž āϰāĻžāĻā§āĨ¤
āĻŦā§āϝāĻŦāĻšāĻžāϰā§āϰ āĻā§āώā§āϤā§āϰ:
- Sleep-onset difficulty â āĻā§āĻŽ āĻāϏāϤ⧠āĻĻā§āϰāĻŋ āĻšāĻā§āĻžāĨ¤
- Circadian rhythm sleep disorders â āĻā§āĻŽā§āϰ āϏāĻŽā§āϏā§āĻāĻŋāϰ āϏāĻŽāϏā§āϝāĻžāĨ¤
- Jet lag â āĻĻā§āϰā§āĻ āĻŦāĻŋāĻŽāĻžāύāĻā§āϰāĻŽāĻŖā§āϰ āĻĒāϰ āĻā§āĻŽā§āϰ āϏāĻŽā§ āĻĒāϰāĻŋāĻŦāϰā§āϤāύāĨ¤
- āĻāĻŋāĻā§ āĻŦāĻŋāĻļā§āώ Circadian-related insomniaāĨ¤
Why Doctor Prescribed It in This Patient?
āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύā§āϰ C/C-āϤ⧠Decreased Sleep āĻāϞā§āϞā§āĻ āϰā§ā§āĻā§āĨ¤
āϏā§āϤāϰāĻžāĻ āĻā§āĻŽā§āϰ āϏāĻŽāϏā§āϝāĻž āĻāĻŽāĻžāύā§āϰ āĻāĻĻā§āĻĻā§āĻļā§āϝ⧠Filfresh āĻĻā§āĻā§āĻž āĻšā§ā§āĻā§ āĻŦāϞ⧠āĻŽāύ⧠āĻšāĻā§āĻā§āĨ¤
PrescriptionâDrug Correlation: High
āĻ āϰā§āĻĨāĻžā§ āϰā§āĻā§āϰ āϞāĻŋāĻāĻŋāϤ āĻ āĻāĻŋāϝā§āĻā§āϰ āϏāĻā§āĻā§ āĻāĻ āĻāώā§āϧā§āϰ āĻāĻĻā§āĻĻā§āĻļā§āϝā§āϰ āĻāĻžāϞ⧠āĻŽāĻŋāϞ āϰā§ā§āĻā§āĨ¤
āϤāĻŦā§ Chronic Insomnia-āĻāϰ āĻā§āώā§āϤā§āϰ⧠Melatonin-āĻā§ āϏāĻŦ āϰā§āĻā§āϰ āĻĒā§āϰāĻĨāĻŽ āϏāĻžāϰāĻŋāϰ āĻāĻŋāĻāĻŋā§āϏāĻž āĻŦāϞāĻž āϝāĻžā§ āύāĻžāĨ¤ CBT-I āĻŦāĻž Cognitive Behavioral Therapy for Insomnia āĻ āϧāĻŋāĻ āĻĒā§āϰāϤāĻŋāώā§āĻ āĻŋāϤ āĻĒā§āϰāĻĨāĻŽ āϏāĻžāϰāĻŋāϰ āĻāĻŋāĻāĻŋā§āϏāĻžāĨ¤
Dose in Prescription
āϏāĻŽā§āĻāĻŦāϤ ā§Ļ+ā§Ļ+ā§§ āĻ āϰā§āĻĨāĻžā§ āϰāĻžāϤ⧠āĻāĻāĻāĻŋāĨ¤
āϏāĻŽā§āϏā§āĻŽāĻž āĻ āϏā§āĻĒāώā§āĻāĨ¤
Side Effects
- Daytime drowsiness â āĻĻāĻŋāύā§āϰ āĻŦā§āϞāĻž āĻā§āĻŽ āĻā§āĻŽ āĻāĻžāĻŦ
- Headache â āĻŽāĻžāĻĨāĻžāĻŦā§āϝāĻĨāĻž
- Dizziness â āĻŽāĻžāĻĨāĻž āĻā§āϰāĻž
Alternative BD Brands
- Melafit 3 mg â Beacon
- Melato 3 mg â Beximco
- Melonin 3 mg â Eskayef
MedEx āĻ āύā§āϝāĻžā§ā§ āĻāĻā§āϞ⧠Melatonin-āĻāϰ āĻŦāĻŋāĻāϞā§āĻĒ āĻŦā§āϰā§āϝāĻžāύā§āĻĄāĨ¤
Clinical Caution: Vertina-D-āĻāϰ Doxylamine āĻāĻŦāĻ FilfreshâāĻĻā§āĻāĻŋāĻ āĻāĻŋāĻŽā§āύāĻŋ āĻŦāĻžā§āĻžāϤ⧠āĻĒāĻžāϰā§āĨ¤ āĻāĻāĻ āϏāĻā§āĻā§ āĻŦā§āϝāĻŦāĻšāĻžāϰ⧠āϏāϤāϰā§āĻāϤāĻž āĻĻāϰāĻāĻžāϰāĨ¤
đ 3. Astagen 2 mg Capsule
Brand Information
| Information | Details |
|---|---|
| BD Brand Name | Astagen |
| Generic Name | Astaxanthin |
| Strength | 2 mg |
| Manufacturer | General Pharmaceuticals Ltd. |
| MedEx Therapeutic Class | Supplements & adjuvant therapy |
| Pharmacological Class | Carotenoid antioxidant |
| Unit Price | ā§ŗ12.03 |
| Pack Price | ā§ŗ361.00 (30 capsules) |
| Other Strength | Astagen 4 mg |
MedEx Link: Astagen 2 mg Capsule
Use of Purpose â āĻā§āύ āĻāĻžāĻā§ āĻŦā§āϝāĻŦāĻšā§āϤ āĻšā§?
Astaxanthin āĻāĻāĻāĻŋ Carotenoid AntioxidantāĨ¤
āĻāĻāĻŋ Antioxidant Supplement āĻšāĻŋāϏā§āĻŦā§ āĻŦāĻžāĻāĻžāϰāĻāĻžāϤ āĻāϰāĻž āĻšā§āĨ¤
MedEx-āĻ āĻŦāĻŋāĻāĻŋāύā§āύ āϏāĻŽā§āĻāĻžāĻŦā§āϝ āĻŦā§āϝāĻŦāĻšāĻžāϰā§āϰ āĻāϞā§āϞā§āĻ āĻāĻā§, āϝā§āĻŽāύ:
- Oxidative stress-related supportive therapy
- āĻāĻŋāĻā§ Cardiovascular āĻ Inflammatory Condition-āĻ āϏāĻšāĻžā§āĻ āĻŦā§āϝāĻŦāĻšāĻžāϰ
- Skin āĻ eye health-āĻāϰ āĻāĻĻā§āĻĻā§āĻļā§āϝ⧠supplementation
āϤāĻŦā§ āĻāϏāĻŦ āĻā§āώā§āϤā§āϰ⧠āĻāĻĒāĻāĻžāϰā§āϰ āĻĒā§āϰāĻŽāĻžāĻŖā§āϰ āĻŽāĻžāύ āĻāĻ āύ⧠āĻāĻŦāĻ Astaxanthin āĻā§āύ⧠āĻĒā§āϰāϤāĻŋāώā§āĻ āĻŋāϤ Vertigo treatment āύā§āĨ¤
Why Doctor Prescribed It in This Patient?
āĻāĻŋāĻāĻŋā§āϏāĻ āĻšā§āϤ⧠Antioxidant āĻŦāĻž general supportive therapy-āĻāϰ āĻāĻĻā§āĻĻā§āĻļā§āϝ⧠āĻĻāĻŋā§ā§āĻā§āύāĨ¤
āĻāĻŋāύā§āϤ⧠Vertigo āĻŦāĻž Insomnia-āĻāϰ āĻāĻŋāĻāĻŋā§āϏāĻžā§ Astaxanthin-āĻāϰ āĻāĻžāϰā§āϝāĻāĻžāϰāĻŋāϤāĻž āĻĒā§āϰāϤāĻŋāώā§āĻ āĻŋāϤ āύā§āĨ¤
Clinical Justification: Uncertain
āϰā§āĻā§āϰ documented findings āĻĻā§āĻā§ Astagen-āĻāϰ āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ āĻĒā§āϰā§ā§āĻāύ āĻĒā§āϰāĻŽāĻžāĻŖ āĻāϰāĻž āϝāĻžāĻā§āĻā§ āύāĻžāĨ¤
Important Prescription Verification
āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠Tab. Astagen āϞā§āĻāĻž āĻŽāύ⧠āĻšāϞā§āĻ MedEx-āĻ Astagen 2 mg Capsule āĻšāĻŋāϏā§āĻŦā§ āϤāĻžāϞāĻŋāĻāĻžāĻā§āĻā§āϤāĨ¤
āĻĢāĻžāϰā§āĻŽā§āϏāĻŋ āĻĨā§āĻā§ āĻāώā§āϧ āύā§āĻā§āĻžāϰ āϏāĻŽā§ āĻāĻāĻŋ āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāĻž āĻāĻāĻŋāϤāĨ¤
đ 4. Bicozin-I Syrup
Brand Information
| Information | Details |
|---|---|
| BD Brand Name | Bicozin-I |
| Generic Name | Iron Polymaltose Complex + Vitamin B Complex + Zinc |
| Manufacturer | Square Pharmaceuticals PLC |
| MedEx Therapeutic Class | Iron & Vitamin Combined preparations |
| Pharmacological Class | Iron supplement + Multivitamin + Mineral supplement |
| Price | ā§ŗ60.00 / 100 ml bottle |
MedEx Link: Bicozin-I Syrup
Composition â āĻĒā§āϰāϤāĻŋ ā§Ģ āĻŽāĻŋāϞāĻŋāϤ⧠āĻāĻĒāĻžāĻĻāĻžāύ
| Generic Component | Strength |
|---|---|
| Elemental Iron | 50 mg |
| Thiamine Hydrochloride (Vitamin B1) | 5 mg |
| Riboflavin (Vitamin B2) | 2 mg |
| Pyridoxine Hydrochloride (Vitamin B6) | 2 mg |
| Nicotinamide (Vitamin B3) | 20 mg |
| Elemental Zinc | 10 mg |
Use of Purpose â āĻā§āύ āϰā§āĻā§ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻšā§?
- Iron deficiency â āĻā§āϰāύā§āϰ āĻāĻžāĻāϤāĻŋāĨ¤
- Iron deficiency anemia â āĻā§āϰāύā§āϰ āĻāĻžāĻāϤāĻŋāĻāύāĻŋāϤ āϰāĻā§āϤāϏā§āĻŦāϞā§āĻĒāϤāĻžāĨ¤
- Vitamin B deficiency â āĻāĻŋāĻāĻžāĻŽāĻŋāύ āĻŦāĻŋ-āĻāϰ āĻāĻžāĻāϤāĻŋāĨ¤
- Zinc deficiency â āĻāĻŋāĻāĻā§āϰ āĻāĻžāĻāϤāĻŋāĨ¤
- Nutritional deficiency â āĻĒā§āώā§āĻāĻŋ āĻāĻĒāĻžāĻĻāĻžāύā§āϰ āĻāĻžāĻāϤāĻŋāĨ¤
Why Doctor Prescribed It in This Patient?
āĻāĻŋāĻāĻŋā§āϏāĻ āĻšā§āϤ⧠āĻĒā§āώā§āĻāĻŋāϰ āĻāĻžāĻāϤāĻŋ āĻĒā§āϰāĻŖ āĻŦāĻž āĻĻā§āϰā§āĻŦāϞāϤāĻžāϰ āϏāĻšāĻžā§āĻ āĻāĻŋāĻāĻŋā§āϏāĻž āĻšāĻŋāϏā§āĻŦā§ āĻĻāĻŋā§ā§āĻā§āύāĨ¤
āϤāĻŦā§ āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠Iron deficiency āĻŦāĻž Vitamin deficiency-āĻāϰ āύāĻŋāĻļā§āĻāĻŋāϤ Diagnosis āύā§āĻāĨ¤
āĻŦāĻŋāĻļā§āώ āĻāϰ⧠Bicozin-I-āϤ⧠Iron āĻāĻā§āĨ¤ āϤāĻžāĻ āĻā§āϰāύā§āϰ āĻāĻžāĻāϤāĻŋ āύāĻž āĻĨāĻžāĻāϞ⧠āĻĻā§āϰā§āĻāĻĻāĻŋāύ āĻāĻāĻŋ āĻŦā§āϝāĻŦāĻšāĻžāϰā§āϰ āĻĒā§āϰā§ā§āĻāύā§ā§āϤāĻž āĻŽā§āϞā§āϝāĻžā§āύ āĻāϰāĻž āĻāĻāĻŋāϤāĨ¤
Dose in Prescription
āϏāĻŽā§āĻāĻŦāϤ ⧍ āĻāĻžāĻŽāĻ āϞā§āĻāĻž āĻāĻā§āĨ¤
āĻāϤāĻŦāĻžāϰ āĻāĻŦāĻ āĻāϤāĻĻāĻŋāύ āĻā§āϤ⧠āĻšāĻŦā§, āϏā§āĻĒāώā§āĻ āύā§āĨ¤
Alternative BD Brands
āĻāĻāĻ Generic Combination-āĻāϰ āĻā§ā§āĻāĻāĻŋ āĻŦā§āϰā§āϝāĻžāύā§āĻĄ:
- Beconex ZI â Renata
- Biozinc-I â Ibn Sina
- Supra-Z â Drug International
- Vitonic â Beximco
- Feziplex â ACME
Important: Bicozin āĻāĻŦāĻ Bicozin-I āĻāĻ āύā§āĨ¤ Bicozin-I-āϤ⧠Iron āϰā§ā§āĻā§, āĻāĻŋāύā§āϤ⧠āϏāĻžāϧāĻžāϰāĻŖ Bicozin-āĻāϰ āĻāĻĒāĻžāĻĻāĻžāύ Vitamin B Complex + ZincāĨ¤
đĄ 8. My Clinical Working Assessment
A. Doctorâs Diagnosis â āĻāĻŋāĻāĻŋā§āϏāĻā§āϰ āϏāĻŽā§āĻāĻžāĻŦā§āϝ āϰā§āĻāύāĻŋāϰā§āĻŖā§
āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠āĻāϞāĻžāĻĻāĻž āĻā§āύ⧠āϏā§āĻĒāώā§āĻ Dx: āϞā§āĻāĻž āĻĒāĻžāĻā§āĻž āϝāĻžā§āύāĻŋāĨ¤
āϤāĻŦā§ C/C āĻ āĻĒā§āϰāĻĻāϤā§āϤ āĻāĻŋāĻāĻŋā§āϏāĻž āĻ āύā§āϝāĻžā§ā§ āĻāĻŋāĻāĻŋā§āϏāĻ āύāĻŋāĻā§āϰ āϏāĻŽāϏā§āϝāĻžāĻā§āϞā§āϰ āĻāĻŋāĻāĻŋā§āϏāĻž āĻāϰāĻā§āύ āĻŦāϞ⧠āĻŽāύ⧠āĻšāĻā§āĻā§āĨ¤
| Probable Clinical Problem | āĻŦāĻžāĻāϞāĻž āĻ āϰā§āĻĨ | Confidence |
|---|---|---|
| Vertigo | āĻŽāĻžāĻĨāĻž āĻā§āϰāĻž | 98% |
| Sleep Disturbance | āĻā§āĻŽā§āϰ āϏāĻŽāϏā§āϝāĻž | 98% |
| Nutritional deficiency | āϏāĻŽā§āĻāĻžāĻŦā§āϝ āĻĒā§āώā§āĻāĻŋāϰ āĻāĻžāĻāϤāĻŋ | 40% |
āĻāĻāĻžāύ⧠Nutritional deficiency āĻā§āĻŦāϞ āϏāĻžāĻĒā§āϞāĻŋāĻŽā§āύā§āĻ āĻĻā§āĻā§āĻžāϰ āϏāĻŽā§āĻāĻžāĻŦā§āϝ āĻāĻĻā§āĻĻā§āĻļā§āϝ; āĻāĻāĻŋ āύāĻŋāĻļā§āĻāĻŋāϤ Diagnosis āύā§āĨ¤
B. My Working Clinical Assessment
Primary Problem: Undifferentiated Vertigo
āĻŦāĻžāĻāϞāĻž: āĻāĻžāϰāĻŖ āĻāĻāύ⧠āύāĻŋāϰā§āϧāĻžāϰāĻŋāϤ āĻšā§āύāĻŋ āĻāĻŽāύ āĻŽāĻžāĻĨāĻž āĻā§āϰāĻžāϰ āϏāĻŽāϏā§āϝāĻžāĨ¤
āĻāĻāĻŋāĻ āĻŦāϰā§āϤāĻŽāĻžāύ⧠āϏāĻŦāĻā§ā§ā§ āϝā§āĻā§āϤāĻŋāϏāĻāĻāϤ Working DiagnosisāĨ¤
Confidence: 95% āϝ⧠āϰā§āĻā§āϰ documented clinical problem VertigoāĨ¤
āĻāĻŋāύā§āϤ⧠Vertigo-āĻāϰ āϏā§āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ āĻāĻžāϰāĻŖ āύāĻŋāϰā§āĻŖā§ā§āϰ āĻāύā§āϝ āĻĒāϰā§āϝāĻžāĻĒā§āϤ āϤāĻĨā§āϝ āύā§āĻāĨ¤
Possible Peripheral Vestibular Disorder
āĻŦāĻžāĻāϞāĻž: āĻāĻžāύā§āϰ āĻā§āϤāϰā§āϰ āĻāĻžāϰāϏāĻžāĻŽā§āϝ āύāĻŋā§āύā§āϤā§āϰāĻŖāĻāĻžāϰ⧠āĻ āĻā§āĻ āĻŦāĻž Vestibular Nerve-āĻāϰ āϏāĻŽāϏā§āϝāĻžāĨ¤
Confidence: Approximately 55% â provisional clinical suspicion, not a validated probability.
āĻāĻžāϰāĻŖ:
- Vertigo āϞā§āĻāĻž āϰā§ā§āĻā§āĨ¤
- āĻāĻŋāύā§āϤ⧠Positional Trigger āϞā§āĻāĻž āύā§āĻāĨ¤
- Nystagmus-āĻāϰ āϤāĻĨā§āϝ āύā§āĻāĨ¤
- Ear examination āĻŦāĻž vestibular assessment āĻĒāĻžāĻā§āĻž āϝāĻžā§āύāĻŋāĨ¤
- Central neurological causes exclusion āĻāϰāĻž āĻšā§ā§āĻā§ āĻāĻŋ āύāĻž āĻāĻžāύāĻž āύā§āĻāĨ¤
Associated Problem: Sleep Disturbance
āĻŦāĻžāĻāϞāĻž: āĻā§āĻŽā§āϰ āϏāĻŽāϏā§āϝāĻžāĨ¤
Confidence: 98% â documented symptom.
Insomnia Disorder āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāϤ⧠āĻāϰāĻ āĻāϤāĻŋāĻšāĻžāϏ āĻĒā§āϰā§ā§āĻāύāĨ¤
Additional Clinical Findings
1. Raised Blood Pressure Reading â āĻāĻā§āĻ āϰāĻā§āϤāĻāĻžāĻĒā§āϰ āϰāĻŋāĻĄāĻŋāĻ: 144/99 mmHg
Confidence: 98%āĨ¤
2. Mild Tachycardia â āĻĒāĻžāϞāϏ āϏāĻžāĻŽāĻžāύā§āϝ āĻĻā§āϰā§āϤ: 103/min
Confidence: 98%āĨ¤
āĻāĻ āĻĻā§āĻāĻŋ finding āĻāĻĒā§āĻā§āώāĻž āĻāϰāĻž āĻāĻāĻŋāϤ āύā§āĨ¤
9. Differential Diagnosis â āϏāĻŽā§āĻāĻžāĻŦā§āϝ āϰā§āĻāϏāĻŽā§āĻš
| Differential Diagnosis | āĻŦāĻžāĻāϞāĻž āĻ āϰā§āĻĨ | āĻā§āϞāĻŋāύāĻŋāĻā§āϝāĻžāϞ āĻŦā§āĻļāĻŋāώā§āĻā§āϝ |
|---|---|---|
| BPPV | āĻŽāĻžāĻĨāĻžāϰ āĻ āĻŦāϏā§āĻĨāĻžāύ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ⧠āĻšāĻ āĻžā§ āĻŽāĻžāĻĨāĻž āĻā§āϰāĻž | āĻ āϞā§āĻĒ āϏāĻŽā§ā§āϰ āĻĒā§āύāϰāĻžāĻŦā§āϤā§āϤ āĻā§āϰā§āĻŖāύ āĻ āύā§āĻā§āϤāĻŋ |
| Vestibular Neuritis | āĻāĻžāϰāϏāĻžāĻŽā§āϝā§āϰ āϏā§āύāĻžā§ā§āϤ⧠āĻĒā§āϰāĻĻāĻžāĻšāĻāύāĻŋāϤ āϏāĻŽāϏā§āϝāĻž | āĻāĻŖā§āĻāĻž āĻĨā§āĻā§ āĻĻāĻŋāύāĻŦā§āϝāĻžāĻĒā§ āϤā§āĻŦā§āϰ Vertigo |
| MÊnièreâs Disease | āĻ āύā§āϤāĻāĻāϰā§āĻŖā§āϰ āĻāĻāĻāĻŋ āϰā§āĻ | Vertigo + Tinnitus + Fluctuating Hearing Loss |
| Vestibular Migraine | āĻŽāĻžāĻāĻā§āϰā§āύ-āϏāĻŽā§āĻĒāϰā§āĻāĻŋāϤ āĻŽāĻžāĻĨāĻž āĻā§āϰāĻž | āĻŽāĻžāĻāĻā§āϰā§āύā§āϰ āĻāϤāĻŋāĻšāĻžāϏ āĻāĻŦāĻ āĻŦāĻžāϰāĻŦāĻžāϰ Vertigo |
| Orthostatic Hypotension | āĻĻāĻžāĻā§āĻžāϞ⧠āϰāĻā§āϤāĻāĻžāĻĒ āĻāĻŽā§ āϝāĻžāĻā§āĻž | āĻļā§ā§āĻž āĻŦāĻž āĻŦāϏāĻž āĻĨā§āĻā§ āĻĻāĻžāĻā§āĻžāϞ⧠āĻŽāĻžāĻĨāĻž āĻšāĻžāϞāĻāĻž āϞāĻžāĻāĻž |
| Cardiac Arrhythmia | āĻšā§āĻĻā§âāϏā§āĻĒāύā§āĻĻāύā§āϰ āĻ āϏā§āĻŦāĻžāĻāĻžāĻŦāĻŋāĻ āĻāύā§āĻĻ | Palpitation, presyncope āĻŦāĻž āĻŽāĻžāĻĨāĻž āĻšāĻžāϞāĻāĻž āϞāĻžāĻāĻž |
| Central Vertigo | āĻŽāϏā§āϤāĻŋāώā§āĻā§āϰ āϏāĻŽāϏā§āϝāĻžāĻāύāĻŋāϤ Vertigo | Neurological signs āĻŦāĻž āĻā§āϰā§āϤāϰ gait instability āĻĨāĻžāĻāϤ⧠āĻĒāĻžāϰ⧠|
Stroke/TIA-āĻāϰ āĻŽāϤ⧠āĻŦāĻŋāĻĒāĻā§āĻāύāĻ āĻāĻžāϰāĻŖāĻā§āϞ⧠āĻĒā§āϰā§ā§āĻāύ āĻ āύā§āϝāĻžā§ā§ āĻŦāĻžāĻĻ āĻĻāĻŋāϤ⧠āĻšāĻŦā§āĨ¤
āĻšāĻ āĻžā§ āĻļā§āϰ⧠āĻšāĻā§āĻž āĻāĻāĻāĻžāύāĻž Vertigo-āĻāϰ āϏāĻā§āĻā§ āĻšāĻžāĻāĻāϤ⧠āύāĻž āĻĒāĻžāϰāĻž, āĻĻā§āĻŦā§āϤ āĻĻā§āώā§āĻāĻŋ, āĻāĻĨāĻž āĻā§āĻŋā§ā§ āϝāĻžāĻā§āĻž, āĻšāĻžāϤ-āĻĒāĻž āĻĻā§āϰā§āĻŦāϞāϤāĻž āĻŦāĻž āύāϤā§āύ āϤā§āĻŦā§āϰ āĻŽāĻžāĻĨāĻžāĻŦā§āϝāĻĨāĻž āĻĨāĻžāĻāϞ⧠āĻāϰā§āϰāĻŋ āĻšāĻžāϏāĻĒāĻžāϤāĻžāϞ⧠āĻŽā§āϞā§āϝāĻžā§āύ āĻĒā§āϰā§ā§āĻāύāĨ¤
10. Doctorâs Diagnosis vs My Diagnosis
| āĻŦāĻŋāώ⧠| Prescribing Doctorâs Assessment | My Assessment |
|---|---|---|
| Vertigo | āĻāϞā§āϞā§āĻ āĻāĻā§ | āĻāĻāĻŽāϤ |
| Sleep problem | āĻāϞā§āϞā§āĻ āĻāĻā§ | āĻāĻāĻŽāϤ |
| BPPV | āϏā§āĻĒāώā§āĻ āϞā§āĻāĻž āύā§āĻ | āĻĒāϰā§āĻā§āώāĻž āĻāĻžā§āĻž āύāĻŋāĻļā§āĻāĻŋāϤ āύ⧠|
| Hypertension | Dx āϞā§āĻāĻž āύā§āĻ | Elevated BP; Hypertension confirmation required |
| Tachycardia | Pulse 103/min āϞā§āĻāĻž āĻāĻā§ | Mild tachycardia |
| Vitamin deficiency | Dx āϏā§āĻĒāώā§āĻ āύ⧠| Laboratory confirmation required |
| Central neurological cause | Assessment āĻĒāĻžāĻā§āĻž āϝāĻžā§āύāĻŋ | āĻĒā§āϰā§ā§āĻāύ āĻ āύā§āϝāĻžā§ā§ āĻŦāĻžāĻĻ āĻĻāĻŋāϤ⧠āĻšāĻŦā§ |
Are Both Diagnoses Similar?
āĻšā§āϝāĻžāĻ, āĻāĻĒāϏāϰā§āĻā§āϰ āĻĒāϰā§āϝāĻžā§ā§ āĻĻā§āĻāĻŋāϰ āĻŽāϧā§āϝ⧠āĻŽāĻŋāϞ āϰā§ā§āĻā§āĨ¤
āĻāĻŋāĻāĻŋā§āϏāĻ Vertigo āĻ Sleep Disturbance āϞāĻŋāĻā§āĻā§āύāĨ¤ āĻāĻŽāĻžāϰ āĻŽā§āϞā§āϝāĻžā§āύā§āĻ āĻāĻā§āϞā§āĻ āĻĒā§āϰāϧāĻžāύ āϏāĻŽāϏā§āϝāĻžāĨ¤
āϤāĻŦā§ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ āĻĒāĻžāϰā§āĻĨāĻā§āϝ āĻšāϞā§:
āĻāĻŋāĻāĻŋā§āϏāĻā§āϰ āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠Vertigo-āĻāϰ āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ Etiology āĻĒāĻžāĻā§āĻž āϝāĻžāĻā§āĻā§ āύāĻžāĨ¤ āĻāĻŽāĻžāϰ āĻŽā§āϞā§āϝāĻžā§āύā§āĻ āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ āĻāĻžāϰāĻŖ āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāĻž āϏāĻŽā§āĻāĻŦ āĻšā§āύāĻŋāĨ¤
āĻ āύā§āϝāĻĻāĻŋāĻā§ BP 144/99 āĻāĻŦāĻ Pulse 103/min āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ āĻ āϤāĻŋāϰāĻŋāĻā§āϤ Findings, āϝā§āĻā§āϞā§āϰ Follow-up āĻĒā§āϰā§ā§āĻāύāĨ¤
Three Major Clinical Concerns
1. Vertigo-āĻāϰ āĻāĻžāϰāĻŖ āύāĻŋāϰā§āĻŖā§ āϏāĻŽā§āĻĒā§āϰā§āĻŖ āĻšā§āύāĻŋāĨ¤
BPPV āĻšāϞ⧠repositioning manoeuvre āĻāĻžāϰā§āϝāĻāϰ; āĻ āύā§āϝāĻĻāĻŋāĻā§ Central Vertigo āĻšāϞ⧠āĻāϰā§āϰāĻŋ āĻŽā§āϞā§āϝāĻžā§āύ āĻĒā§āϰā§ā§āĻāύ āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤
2. Vertina-D āĻ Filfresh āĻāĻāϏāĻā§āĻā§ āĻāĻŋāĻŽā§āύāĻŋ āĻŦāĻžā§āĻžāϤ⧠āĻĒāĻžāϰā§āĨ¤
āĻāĻā§ āĻĨā§āĻā§āĻ āĻŽāĻžāĻĨāĻž āĻā§āϰāĻžāϰ āĻ āĻāĻŋāϝā§āĻ āĻĨāĻžāĻāĻžā§ Fall Risk āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖāĨ¤
3. Astagen āĻ Bicozin-I-āĻāϰ āĻĒā§āϰā§ā§āĻāύā§ā§āϤāĻž āύāĻŋāĻļā§āĻāĻŋāϤ āύā§āĨ¤
āϰā§āĻā§āϰ āĻāύā§āϝ āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ āĻāĻĒāĻāĻžāϰā§āϰ āĻĒā§āϰāĻŽāĻžāĻŖ āĻŦāĻž Nutritional Deficiency-āĻāϰ Diagnosis āĻĒāĻžāĻā§āĻž āϝāĻžā§āύāĻŋāĨ¤
11. Recommended Further Investigations
āĻŦāϰā§āϤāĻŽāĻžāύ⧠āϏāĻŦāĻā§ā§ā§ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ āĻšāϞ⧠Clinical AssessmentāĨ¤
A. Clinical Examination
- DixâHallpike Test: BPPV āĻļāύāĻžāĻā§āϤā§āϰ āĻāύā§āϝ, āĻāĻĒāϝā§āĻā§āϤ Positional Vertigo āĻĨāĻžāĻāϞā§āĨ¤
- Neurological Examination: Central cause-āĻāϰ āϞāĻā§āώāĻŖ āĻŽā§āϞā§āϝāĻžā§āύāĨ¤
- Nystagmus Examination: āĻā§āĻā§āϰ āĻ āϏā§āĻŦāĻžāĻāĻžāĻŦāĻŋāĻ āύā§āĻžāĻā§āĻž āĻĒāϰā§āĻā§āώāĻžāĨ¤
- Orthostatic BP and Pulse: āĻļā§ā§āĻž āĻ āĻĻāĻžāĻā§āĻžāύ⧠āĻ āĻŦāϏā§āĻĨāĻžā§ BP āĻāĻŦāĻ PulseāĨ¤
- Otoscopy and Hearing Assessment: āĻāĻžāύā§āϰ āϰā§āĻ āĻŦāĻž āĻļā§āϰāĻŦāĻŖ āϏāĻŽāϏā§āϝāĻž āύāĻŋāϰā§āĻŖā§āĨ¤
HINTS āĻĒāϰā§āĻā§āώāĻž āĻļā§āϧ⧠āĻāĻĒāϝā§āĻā§āϤ Acute Vestibular Syndrome-āĻ āĻĒā§āϰāĻļāĻŋāĻā§āώāĻŋāϤ āĻāĻŋāĻāĻŋā§āϏāĻ āĻāϰāĻŦā§āύāĨ¤
B. Laboratory Investigations
āϰā§āĻā§āϰ āĻāϤāĻŋāĻšāĻžāϏ, āĻĒāϰā§āĻā§āώāĻž āĻāĻŦāĻ āĻĒā§āϰā§āĻŦā§āϰ āϰāĻŋāĻĒā§āϰā§āĻ āĻ āύā§āϝāĻžā§ā§:
| Investigation | Why Needed |
|---|---|
| CBC | Anemia āĻŦāĻž āĻ āύā§āϝāĻžāύā§āϝ āϰāĻā§āϤā§āϰ āϏāĻŽāϏā§āϝāĻž āĻŽā§āϞā§āϝāĻžā§āύ |
| Fasting Glucose / HbA1c | Diabetes screening, āĻĒā§āϰā§ā§āĻāύ āĻ āύā§āϝāĻžā§ā§ |
| Serum Electrolytes | Sodium, Potassium āĻāϤā§āϝāĻžāĻĻāĻŋāϰ āĻ āϏā§āĻŦāĻžāĻāĻžāĻŦāĻŋāĻāϤāĻž |
| Serum Creatinine/eGFR | Kidney Function |
| TSH | Thyroid Disorder āϏāύā§āĻĻā§āĻš āĻĨāĻžāĻāϞ⧠|
| Serum Ferritin | Iron deficiency āϏāύā§āĻĻā§āĻš āĻšāϞ⧠|
| ECG / Holter ECG | Palpitation, unexplained tachycardia āĻŦāĻž intermittent arrhythmia āϏāύā§āĻĻā§āĻšā§ |
| ABPM/HBPM | Hypertension āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāϤ⧠|
MRI Brain: āϏāĻŦāĻžāϰ āĻāύā§āϝ āĻĒā§āϰā§ā§āĻāύ āύā§āĨ¤ Central Neurological Cause āϏāύā§āĻĻā§āĻš āĻšāϞ⧠āĻŦāĻŋāĻļā§āώāĻā§āĻā§āϰ āĻŽā§āϞā§āϝāĻžā§āύ āĻ āύā§āϝāĻžā§ā§ MRI āĻĒā§āϰā§ā§āĻāύ āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤
12. Bangladesh-Available Drugs for Vertigo
āύāĻŋāĻā§āϰ āĻāώā§āϧāĻā§āϞ⧠āĻŦāĻžāĻāϞāĻžāĻĻā§āĻļā§ āĻĒāĻžāĻā§āĻž āϝāĻžā§āĨ¤ āĻāĻā§āϞ⧠āĻŦāĻŋāĻāĻŋāύā§āύ āĻāĻžāϰāĻŖā§āϰ Vertigo āĻŦāĻž associated nausea-āϤ⧠āĻāĻŋāĻāĻŋā§āϏāĻā§āϰāĻž āĻŦāĻŋāĻŦā§āĻāύāĻž āĻāϰāϤ⧠āĻĒāĻžāϰā§āύāĨ¤
āĻāĻāĻŋ āϰā§āĻā§āĻā§ āϏāĻŦ āĻāώā§āϧ āĻĻā§āĻā§āĻžāϰ āϤāĻžāϞāĻŋāĻāĻž āύā§āĨ¤ āϰā§āĻā§āϰ āĻĒā§āϰāĻā§āϤāĻŋ āĻ āύā§āϝāĻžā§ā§ āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ āĻāώā§āϧ āύāĻŋāϰā§āĻŦāĻžāĻāύ āĻāϰāϤ⧠āĻšāĻŦā§āĨ¤
1. Betahistine Dihydrochloride
Bangladesh Brands: Betatin, Menaril, Vectra, Vertinor, VesercāĨ¤
MedEx Therapeutic Class: Drugs used in meniereâs diseases.
Pharmacological Class: Histamine analogueāĨ¤
Used For: MÊnièreâs disease-related Vertigo āĻāĻŦāĻ āϏāĻāĻļā§āϞāĻŋāώā§āĻ āĻāĻĒāϏāϰā§āĻāĨ¤
āĻŦāĻžāĻāϞāĻžā§: āĻāĻžāύā§āϰ āĻā§āϤāϰā§āϰ āĻāĻžāϰāϏāĻžāĻŽā§āϝāĻāύāĻŋāϤ āĻāĻŋāĻā§ āϏāĻŽāϏā§āϝāĻžā§ āĻŽāĻžāĻĨāĻž āĻā§āϰāĻž āĻāĻŽāĻžāϤ⧠āĻŦā§āϝāĻŦāĻšā§āϤ āĻšā§āĨ¤
MedEx: Betahistine â Available Brands
2. Cinnarizine
Bangladesh Brands: Cinaron, Cinazin, Cinarin, ZincināĨ¤
MedEx Therapeutic Class: Anti vertigo drugs.
Pharmacological Class: Antihistamine with calcium-channel blocking propertiesāĨ¤
Used For: āĻāĻŋāĻā§ Peripheral Vestibular Disorder āĻāĻŦāĻ Motion SicknessāĨ¤
āĻŦāĻžāĻāϞāĻžā§: āĻāĻžāύā§āϰ āĻāĻžāϰāϏāĻžāĻŽā§āϝāĻāύāĻŋāϤ āĻŽāĻžāĻĨāĻž āĻā§āϰāĻž āĻ āĻŦāĻŽāĻŋ āĻŦāĻŽāĻŋ āĻāĻžāĻŦ āĻāĻŽāĻžāϤ⧠āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻāϰāĻž āĻšā§āĨ¤
MedEx: Cinnarizine â Generic Information
3. Meclizine Hydrochloride
Bangladesh Brands: Avert, Meczin, Clizin, MelizināĨ¤
MedEx Therapeutic Class: Anti-emetic drugs.
Pharmacological Class: First-generation H1 antihistamineāĨ¤
Used For: Motion sickness āĻāĻŦāĻ āĻāĻŋāĻā§ Vestibular Disorder-āĻāϰ āĻāĻĒāϏāϰā§āĻ āĻāĻŽāĻžāϤā§āĨ¤
āĻŦāĻžāĻāϞāĻžā§: āĻŽāĻžāĻĨāĻž āĻā§āϰāĻž, āĻŦāĻŽāĻŋ āĻŦāĻŽāĻŋ āĻāĻžāĻŦ āĻ āĻāϞāĻžāĻāϞāĻāύāĻŋāϤ āĻ āϏā§āϏā§āĻĨāϤāĻžā§ āϏā§āĻŦāϞā§āĻĒāĻŽā§ā§āĻžāĻĻāĻŋ āĻāĻĒāϏāϰā§āĻ āύāĻŋā§āύā§āϤā§āϰāĻŖā§ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻšā§āĨ¤
MedEx: Meclizine â Available Brands
4. Prochlorperazine Maleate
Bangladesh Brands: Stemetil, Vergon, Promtil, VertiganāĨ¤
MedEx Therapeutic Class: Anti vertigo drugs, Anti-emetic drugs.
Pharmacological Class: Phenothiazine derivative / Dopamine D2 receptor antagonistāĨ¤
Used For: Severe nausea, vomiting āĻāĻŦāĻ āĻāĻŋāĻā§ Vestibular Vertigo-āĻāϰ āĻāĻĒāϏāϰā§āĻāĨ¤
āĻŦāĻžāĻāϞāĻžā§: āϤā§āĻŦā§āϰ āĻŦāĻŽāĻŋ āĻŦāĻŽāĻŋ āĻāĻžāĻŦ āĻ āĻŽāĻžāĻĨāĻž āĻā§āϰāĻžāϰ āĻāĻĒāϏāϰā§āĻ āϏā§āĻŦāϞā§āĻĒāĻŽā§ā§āĻžāĻĻā§ āĻāĻŽāĻžāύā§āϰ āĻāύā§āϝ āĻŦā§āϝāĻŦāĻšā§āϤ āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤
MedEx: Prochlorperazine â Available Brands
5. Meclizine + Pyridoxine
Bangladesh Brands: Mecliz Plus, Acliz Plus, AnvertāĨ¤
MedEx Therapeutic Class: Anti-emetic drugs.
Pharmacological Class: H1 antihistamine + Vitamin B6āĨ¤
Used For: Vestibular Disorder-associated Vertigo, nausea āĻ vomiting-āĻāϰ āĻāĻĒāϏāϰā§āĻāĨ¤
MedEx: Meclizine + Pyridoxine
Important Guideline Note
āϝāĻĻāĻŋ āϰā§āĻā§āϰ BPPV āύāĻŋāĻļā§āĻāĻŋāϤ āĻšā§, āϤāĻžāĻšāϞ⧠āύāĻŋā§āĻŽāĻŋāϤ Antihistamine āĻŦāĻž Vestibular Suppressant āĻĻā§āĻā§āĻžāĻ āĻĒā§āϰāϧāĻžāύ āĻāĻŋāĻāĻŋā§āϏāĻž āύā§āĨ¤
AAO-HNS Guideline āĻ āύā§āϝāĻžā§ā§ Posterior Canal BPPV-āĻāϰ āĻāύā§āϝ āĻāĻĒāϝā§āĻā§āϤ Epley Manoeuvre āĻšāϞ⧠āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ āĻāĻŋāĻāĻŋā§āϏāĻžāĨ¤
āĻāĻāĻŋ trained clinician āĻĻā§āĻŦāĻžāϰāĻž āĻāϰāĻž āĻāĻāĻŋāϤāĨ¤
13. Management & Treatment Plan
Step 1 â Establish the Cause of Vertigo
āĻĒā§āϰāĻĨāĻŽā§ āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāϤ⧠āĻšāĻŦā§:
- āĻŽāĻžāĻĨāĻž āĻā§āϰāĻž āĻāϤāĻĻāĻŋāύ āϧāϰ⧠āĻšāĻā§āĻā§?
- āĻĒā§āϰāϤāĻŋāĻŦāĻžāϰ āĻāϤāĻā§āώāĻŖ āĻĨāĻžāĻā§?
- āĻŽāĻžāĻĨāĻž āĻā§āϰāĻžāϰ āϏāĻā§āĻā§ Hearing Loss āĻŦāĻž Tinnitus āĻāĻā§ āĻāĻŋ āύāĻž?
- Position āĻĒāϰāĻŋāĻŦāϰā§āϤāύā§āϰ āϏāĻā§āĻā§ āϏāĻŽā§āĻĒāϰā§āĻ āĻāĻā§ āĻāĻŋ āύāĻž?
- Neurological Red Flags āĻāĻā§ āĻāĻŋ āύāĻž?
Step 2 â Manage According to Diagnosis
If BPPV is confirmed:
- Canalith Repositioning Manoeuvre, āϝā§āĻŽāύ EpleyāĨ¤
- āĻĒā§āϰā§ā§āĻāύ āĻ āύā§āϝāĻžā§ā§ Vestibular RehabilitationāĨ¤
- Routine Vestibular Suppressant āĻā§āĻŋā§ā§ āĻāϞāĻžāĨ¤
If MÊnièreâs Disease is suspected:
- ENT AssessmentāĨ¤
- AudiometryāĨ¤
- āϰā§āĻ āĻ āύā§āϝāĻžā§ā§ Betahistine āĻŦāĻž āĻ āύā§āϝ āĻŦā§āϝāĻŦāϏā§āĻĨāĻžāĻĒāύāĻž āĻŦāĻŋāĻŦā§āĻāύāĻžāĨ¤
If Vestibular Neuritis is suspected:
- Central Cause āĻŦāĻžāĻĻ āĻĻā§āĻā§āĻžāĨ¤
- āϏā§āĻŦāϞā§āĻĒāĻŽā§ā§āĻžāĻĻāĻŋ Symptomatic TreatmentāĨ¤
- Vestibular RehabilitationāĨ¤
- Selected acute cases-āĻ specialist assessment āĻ āύā§āϝāĻžā§ā§ āĻ āύā§āϝāĻžāύā§āϝ āĻāĻŋāĻāĻŋā§āϏāĻžāĨ¤
Step 3 â Assess Sleep Disturbance
- Sleep HistoryāĨ¤
- āύāĻŋā§āĻŽāĻŋāϤ āĻā§āĻŽā§āϰ āϏāĻŽā§āϏā§āĻāĻŋāĨ¤
- Caffeine āĻ stimulant intake āĻŽā§āϞā§āϝāĻžā§āύāĨ¤
- Anxiety āĻŦāĻž Sleep Apnea-āĻāϰ āĻŽāϤ⧠āĻāĻžāϰāĻŖ āĻ āύā§āϏāύā§āϧāĻžāύāĨ¤
- Persistent Insomnia āĻšāϞ⧠CBT-I āĻŦāĻŋāĻŦā§āĻāύāĻžāĨ¤
Step 4 â Recheck Blood Pressure
- āϏāĻ āĻŋāĻ āĻĒāĻĻā§āϧāϤāĻŋāϤ⧠āĻĒā§āύāϰāĻžā§ BP āĻŽāĻžāĻĒāĻžāĨ¤
- āĻĒā§āϰā§ā§āĻāύ⧠⧠āĻĻāĻŋāύā§āϰ Home BP MonitoringāĨ¤
- Hypertension āύāĻŋāĻļā§āĻāĻŋāϤ āĻšāϞ⧠cardiovascular risk āĻāĻŦāĻ comorbidity āĻ āύā§āϝāĻžā§ā§ āĻāĻŋāĻāĻŋā§āϏāĻžāĨ¤
NICE NG136 āĻ āύā§āϝāĻžā§ā§ āĻāĻāĻāĻŋ Clinic BP Reading āĻĻāĻŋā§ā§ āϏā§āĻĨāĻžā§ā§ Hypertension āύāĻŋāϰā§āĻŖā§ āĻāϰāĻž āĻāĻāĻŋāϤ āύā§āĨ¤
Step 5 â Medication Review
āĻŦāϰā§āϤāĻŽāĻžāύ Prescribed Drugs-āĻāϰ āĻŽāϧā§āϝā§:
- Vertina-D-āĻāϰ āϏā§āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ indication āĻāĻŦāĻ dose āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāĻžāĨ¤
- Filfresh-āĻāϰ āĻĒā§āϰā§ā§āĻāύ, āϏāĻŽā§āĻāĻžāϞ āĻāĻŦāĻ daytime sedation āĻŽā§āϞā§āϝāĻžā§āύāĨ¤
- Astagen-āĻāϰ āϏā§āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ āĻĒā§āϰā§ā§āĻāύ āĻĒāϰā§āϝāĻžāϞā§āĻāύāĻžāĨ¤
- Bicozin-I-āĻāϰ āĻāύā§āϝ Iron āĻŦāĻž Nutritional Deficiency āĻāĻā§ āĻāĻŋ āύāĻž āĻĻā§āĻāĻžāĨ¤
14. Referral â āĻā§āύ āĻŦāĻŋāĻļā§āώāĻā§āĻā§āϰ āĻāĻžāĻā§ āĻĒāĻžāĻ āĻžāĻŦā§āύ?
Primary Referral: ENT Specialist
Department: ENT / Otolaryngology
āĻŦāĻžāĻāϞāĻž: āύāĻžāĻ-āĻāĻžāύ-āĻāϞāĻž āĻŦāĻŋāĻļā§āώāĻā§āĻāĨ¤
Reason: Persistent or recurrent Vertigo requiring evaluation for vestibular disorders.
āĻŦāĻŋāĻļā§āώ āĻāϰā§:
- Positional Vertigo
- Tinnitus
- Hearing Loss
- Suspected MÊnièreâs Disease
- Suspected BPPV
Neurologist Referral
āϝāĻāύ:
- Central Vertigo āϏāύā§āĻĻā§āĻš āĻšā§āĨ¤
- Vestibular Migraine āϏāύā§āĻĻā§āĻš āĻšā§āĨ¤
- Neurological Symptoms āĻĨāĻžāĻā§āĨ¤
- Vertigo-āĻāϰ āĻāĻžāϰāĻŖ āϏā§āĻĒāώā§āĻ āύ⧠āĻāĻŦāĻ āϞāĻā§āώāĻŖ āĻ āĻŦā§āϝāĻžāĻšāϤ āĻĨāĻžāĻā§āĨ¤
Stroke-āĻāϰ Red Flag āĻĨāĻžāĻāϞ⧠Routine Neurology Appointment āύā§; āϏāϰāĻžāϏāϰāĻŋ Emergency Department-āĻ āĻĒāĻžāĻ āĻžāϤ⧠āĻšāĻŦā§āĨ¤
Medicine Specialist
BP 144/99 mmHg āĻāĻŦāĻ Pulse 103/min-āĻāϰ āĻāĻžāϰāĻŖ āĻ āĻā§āĻāĻāĻŋ āĻŽā§āϞā§āϝāĻžā§āύā§āϰ āĻāύā§āϝ Medicine Specialist-āĻ āĻāĻĒāϝā§āĻā§āϤāĨ¤
15. Prescription Diagnosis Note â Clinically āĻā§ āϞāĻŋāĻāĻŦā§āύ?
āĻŦāϰā§āϤāĻŽāĻžāύ āϤāĻĨā§āϝ āĻ āύā§āϝāĻžā§ā§ āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠āϏāĻŦāĻā§ā§ā§ āĻā§āϰāĻšāĻŖāϝā§āĻā§āϝ Working Diagnosis:
Suggested Clinical Diagnosis
Dx:
1. Vertigo â Etiology under evaluation (R42)
āĻŦāĻžāĻāϞāĻž: āĻŽāĻžāĻĨāĻž āĻā§āϰāĻž â āĻāĻžāϰāĻŖ āύāĻŋāϰā§āĻŖā§āĻžāϧā§āύāĨ¤
2. Sleep Disturbance
āĻŦāĻžāĻāϞāĻž: āĻā§āĻŽā§āϰ āϏāĻŽāϏā§āϝāĻžāĨ¤
3. Elevated Blood Pressure Reading â R03.0
āĻŦāĻžāĻāϞāĻž: āĻāĻā§āĻ āϰāĻā§āϤāĻāĻžāĻĒā§āϰ āϰāĻŋāĻĄāĻŋāĻ; Hypertension āĻāĻāύ⧠āύāĻŋāĻļā§āĻāĻŋāϤ āύā§āĨ¤
4. Mild Tachycardia (Pulse 103/min)
āĻŦāĻžāĻāϞāĻž: āĻĒāĻžāϞāϏ āϏāĻžāĻŽāĻžāύā§āϝ āĻĻā§āϰā§āϤāĨ¤
Concise Prescription Version
Working Dx: Vertigo (etiology undetermined) with sleep disturbance; raised BP reading and mild tachycardia.
āĻŦāĻžāĻāϞāĻž: āĻāĻžāϰāĻŖ āĻ āύāĻŋāϰā§āϧāĻžāϰāĻŋāϤ āĻŽāĻžāĻĨāĻž āĻā§āϰāĻž, āϏāĻā§āĻā§ āĻā§āĻŽā§āϰ āϏāĻŽāϏā§āϝāĻž, āĻāĻā§āĻ āϰāĻā§āϤāĻāĻžāĻĒā§āϰ āϰāĻŋāĻĄāĻŋāĻ āĻāĻŦāĻ āϏāĻžāĻŽāĻžāύā§āϝ āĻĻā§āϰā§āϤ āĻĒāĻžāϞāϏāĨ¤
āĻāĻāύāĻ BPPV, MÊnièreâs Disease, Chronic Insomnia āĻŦāĻž Established Hypertension āϞāĻŋāĻā§ āĻĻā§āĻā§āĻž āϝāĻĨāĻžāϝāĻĨ āύā§āĨ¤
16. Referral Note for Prescription
To: Consultant, ENT / Otolaryngology
Clinical Note:
Patient aged approximately 50 years presenting with vertigo and reduced sleep. Recorded BP 144/99 mmHg and pulse 103/min. Kindly evaluate for peripheral vestibular pathology, including BPPV and other causes of vertigo, and advise further management.
āĻŦāĻžāĻāϞāĻž āĻ āϰā§āĻĨ:
āĻāύā§āĻŽāĻžāύāĻŋāĻ ā§Ģā§Ļ āĻŦāĻāϰ āĻŦā§āϏ⧠āϰā§āĻā§ āĻŽāĻžāĻĨāĻž āĻā§āϰāĻž āĻ āĻā§āĻŽā§āϰ āϏāĻŽāϏā§āϝāĻžāϰ āĻ āĻāĻŋāϝā§āĻ āύāĻŋā§ā§ āĻāϏā§āĻā§āύāĨ¤ āϰāĻā§āϤāĻāĻžāĻĒ ā§§ā§Ēā§Ē/⧝⧝ mmHg āĻāĻŦāĻ āĻĒāĻžāϞāϏ ā§§ā§Ļā§Š/min āĻĒāĻžāĻā§āĻž āĻā§āĻā§āĨ¤ āϰā§āĻā§āϰ āĻāĻžāύā§āϰ āĻāĻžāϰāϏāĻžāĻŽā§āϝāĻāύāĻŋāϤ āϏāĻŽāϏā§āϝāĻž, BPPV āĻŦāĻž āĻŽāĻžāĻĨāĻž āĻā§āϰāĻžāϰ āĻ āύā§āϝāĻžāύā§āϝ āĻāĻžāϰāĻŖ āύāĻŋāϰā§āĻŖā§ āĻāĻŦāĻ āĻĒā§āϰā§ā§āĻāύā§ā§ āĻāĻŋāĻāĻŋā§āϏāĻžāϰ āĻāύā§āϝ āĻŦāĻŋāĻļā§āώāĻā§āĻā§āϰ āĻĒāϰāĻžāĻŽāϰā§āĻļ āĻāĻžāĻŽā§āϝāĨ¤
17. Overview / Summary â āϏāĻžāϰāϏāĻāĻā§āώā§āĻĒ
| Clinical Finding | Final Assessment | Confidence |
|---|---|---|
| Vertigo | Documented Clinical Symptom | 98% |
| Reduced Sleep | Documented Clinical Symptom | 98% |
| Elevated BP | 144/99 mmHg | 98% |
| Mild Tachycardia | Pulse 103/min | 98% |
| Peripheral Vestibular Disease | Possible | 55% |
| Specific BPPV Diagnosis | Insufficient evidence | Low |
| Established Hypertension | Not confirmed | Low |
| Nutritional Deficiency | Not established | Low |
Confidence Scores are subjective assessments of the available documentation, not statistically validated diagnostic probabilities.
Final Clinical Conclusion
āĻāĻ āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ āĻ āύā§āϝāĻžā§ā§ āϰā§āĻā§āϰ āĻĒā§āϰāϧāĻžāύ āϏāĻŽāϏā§āϝāĻž āĻšāϞ⧠Vertigo āĻŦāĻž āĻŽāĻžāĻĨāĻž āĻā§āϰāĻž āĻāĻŦāĻ Sleep Disturbance āĻŦāĻž āĻā§āĻŽā§āϰ āϏāĻŽāϏā§āϝāĻžāĨ¤
āϏāĻā§āĻā§ Elevated Blood Pressure (144/99 mmHg) āĻ Mild Tachycardia (103/min) āϰā§ā§āĻā§āĨ¤
āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ Vestibular Disorder, āϝā§āĻŽāύ BPPV, āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāĻžāϰ āĻŽāϤ⧠āĻĒāϰā§āϝāĻžāĻĒā§āϤ āϤāĻĨā§āϝ āύā§āĻāĨ¤
My Final Working Diagnosis: Undifferentiated Vertigo with Associated Sleep Disturbance, Elevated BP Reading and Mild Tachycardia.
18. Actionable Plan â āĻāĻŋāĻāĻŋā§āϏāĻā§āϰ āĻĒāϰāĻŦāϰā§āϤ⧠āĻāϰāĻŖā§ā§
- āϰā§āĻā§āϰ Vertigo-āĻāϰ āϏāĻŽā§āĻāĻžāϞ, Trigger āĻāĻŦāĻ Associated Symptoms āϏāĻāĻā§āϰāĻš āĻāϰā§āύāĨ¤
- Neurological Examination āĻ āĻāĻĒāϝā§āĻā§āϤ Vestibular Examination āĻāϰā§āύāĨ¤
- BP āĻĒā§āύāϰāĻžā§ āĻŽā§āĻĒā§ āĻĒā§āϰā§ā§āĻāύ āĻ āύā§āϝāĻžā§ā§ ABPM/HBPM āĻāϰā§āύāĨ¤
- ECG āĻ CBC-āϏāĻš āĻĒā§āϰā§āĻŦā§āϰ āĻĒāϰā§āĻā§āώāĻžāĻā§āϞā§āϰ āĻŽā§āϞ āϰāĻŋāĻĒā§āϰā§āĻ āϏāĻāĻā§āϰāĻš āĻāϰā§āύāĨ¤
- Vertina-D, Filfresh, Astagen āĻ Bicozin-I-āĻāϰ Indication āĻāĻŦāĻ Dose āĻĒā§āύāϰā§āĻŽā§āϞā§āϝāĻžā§āύ āĻāϰā§āύāĨ¤
- āĻĒā§āϰā§ā§āĻāύ āĻ āύā§āϝāĻžā§ā§ ENT āĻ Medicine Specialist-āĻāϰ āĻāĻžāĻā§ Refer āĻāϰā§āύāĨ¤
āĻšāĻ āĻžā§ āϤā§āĻŦā§āϰ āĻŽāĻžāĻĨāĻž āĻā§āϰāĻž, āĻšāĻžāĻāĻāϤ⧠āύāĻž āĻĒāĻžāϰāĻž, āĻāĻāĻĒāĻžāĻļ āĻĻā§āϰā§āĻŦāϞ āĻšāĻā§āĻž, āĻāĻĨāĻž āĻā§āĻŋā§ā§ āϝāĻžāĻā§āĻž, āύāϤā§āύ āĻĻā§āĻŦā§āϤ āĻĻā§āώā§āĻāĻŋ āĻ āĻĨāĻŦāĻž āĻ āĻā§āĻāĻžāύ āĻšāĻā§āĻžāϰ āĻŽāϤ⧠āĻāĻĒāϏāϰā§āĻ āĻĨāĻžāĻāϞ⧠āĻāϰā§āϰāĻŋ āĻšāĻžāϏāĻĒāĻžāϤāĻžāϞ⧠āĻĒāĻžāĻ āĻžāύāĨ¤
19. Reference List â Textbook + Guideline + DOI
A. Standard Medical Textbooks
1. Harrisonâs Principles of Internal Medicine.
22nd Edition. McGraw Hill, 2025.
Chapter 24: Dizziness and Vertigo.
2. Davidsonâs Principles and Practice of Medicine.
25th Edition. Elsevier, 2026.
Chapter 27: Neurology and Stroke Medicine.
3. Katzungâs Basic & Clinical Pharmacology.
16th Edition. McGraw Hill, 2024.
Chapter 16: Histamine, Serotonin, Anti-Obesity Drugs, and the Ergot Alkaloids.
B. International Clinical Guidelines
4. NICE Guideline NG127.
Suspected Neurological Conditions: Recognition and Referral, 2019.
Vertigo, BPPV and Vestibular Migraine assessment.
5. NICE Guideline NG136.
Hypertension in Adults: Diagnosis and Management.
Published 2019; subsequently updated.
6. American Academy of OtolaryngologyâHead and Neck Surgery Foundation.
Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update), 2017.
DOI: 10.1177/0194599816689667
C. Peer-Reviewed Journals with DOI
7. Edlow JA, et al.
Guidelines for Reasonable and Appropriate Care in the Emergency Department 3 (GRACE-3): Acute Dizziness and Vertigo in the Emergency Department.
Academic Emergency Medicine. 2023;30:442â486.
DOI: 10.1111/acem.14728
8. Qaseem A, et al.
Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians.
Annals of Internal Medicine. 2016;165(2):125â133.
DOI: 10.7326/M15-2175
D. Bangladesh Drug Reference
9. MedEx Bangladesh: Drug indications, generic compositions, therapeutic classifications, manufacturers and listed Bangladesh prices.
āϏāĻŦāĻļā§āώ⧠āϤāĻŋāύāĻāĻŋ āϤāĻĨā§āϝ āĻāĻžāύāϤ⧠āĻāĻžāĻ:
ā§§. āϰā§āĻā§ āĻĒā§āϰā§āώ āύāĻžāĻāĻŋ āĻŽāĻšāĻŋāϞāĻž?
⧍. āĻŽāĻžāĻĨāĻž āĻā§āϰāĻžāĻāĻž āĻāĻŋ āĻŦāĻŋāĻāĻžāύāĻžā§ āĻĒāĻžāĻļ āĻĢāĻŋāϰāϞ⧠āĻŦāĻž āĻŽāĻžāĻĨāĻž āύā§āĻžāϞ⧠āĻšā§, āύāĻžāĻāĻŋ āϏāĻžāϰāĻžāĻā§āώāĻŖ āĻĨāĻžāĻā§?
ā§Š. āĻŽāĻžāĻĨāĻž āĻā§āϰāĻžāϰ āϏāĻā§āĻā§ āĻāĻŋ āĻāĻžāύ⧠āĻļāĻŦā§āĻĻ, āĻļā§āϰāĻŦāĻŖāĻļāĻā§āϤāĻŋ āĻāĻŽā§ āϝāĻžāĻā§āĻž, āĻŦāĻŽāĻŋ āĻŦāĻŽāĻŋ āĻāĻžāĻŦ āĻ āĻĨāĻŦāĻž āĻšāĻžāĻāĻāϤ⧠āĻāĻžāϰāϏāĻžāĻŽā§āϝā§āϰ āϏāĻŽāϏā§āϝāĻž āĻāĻā§?
āĻāĻ āϤāĻĨā§āϝāĻā§āϞ⧠āĻĒā§āϞ⧠āϏāĻŽā§āĻāĻžāĻŦā§āϝ Peripheral Vertigo, BPPV, Vestibular Migraine āĻāĻŦāĻ Central Vertigo-āĻāϰ āĻŽāϧā§āϝ⧠āĻāϰāĻ āύāĻŋāϰā§āĻāϰāϝā§āĻā§āϝāĻāĻžāĻŦā§ āĻĒāĻžāϰā§āĻĨāĻā§āϝ āĻāϰ⧠Working Diagnosis āύāĻŋāϰā§āϧāĻžāϰāĻŖ āĻāϰāĻž āϝāĻžāĻŦā§āĨ¤
Md.Rafiqul Islam Lipu